BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38281962)

  • 1. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.
    Mei S; Alchahin AM; Tsea I; Kfoury Y; Hirz T; Jeffries NE; Zhao T; Xu Y; Zhang H; Sarkar H; Wu S; Subtelny AO; Johnsen JI; Zhang Y; Salari K; Wu CL; Randolph MA; Scadden DT; Dahl DM; Shin J; Kharchenko PV; Saylor PJ; Sykes DB; Baryawno N
    Genome Med; 2024 Jan; 16(1):1. PubMed ID: 38281962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.
    Wang L; Yang G; Zhao D; Wang J; Bai Y; Peng Q; Wang H; Fang R; Chen G; Wang Z; Wang K; Li G; Yang Y; Wang Z; Guo P; Peng L; Hou D; Xu W
    Mol Cancer; 2019 Apr; 18(1):86. PubMed ID: 30975145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma.
    Alchahin AM; Mei S; Tsea I; Hirz T; Kfoury Y; Dahl D; Wu CL; Subtelny AO; Wu S; Scadden DT; Shin JH; Saylor PJ; Sykes DB; Kharchenko PV; Baryawno N
    Nat Commun; 2022 Sep; 13(1):5747. PubMed ID: 36180422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tumor-stromal interactions in bone metastasis.
    Esposito M; Kang Y
    Pharmacol Ther; 2014 Feb; 141(2):222-33. PubMed ID: 24140083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma.
    Davidson G; Helleux A; Vano YA; Lindner V; Fattori A; Cerciat M; Elaidi RT; Verkarre V; Sun CM; Chevreau C; Bennamoun M; Lang H; Tricard T; Fridman WH; Sautes-Fridman C; Su X; Plassard D; Keime C; Thibault-Carpentier C; Barthelemy P; Oudard SM; Davidson I; Malouf GG
    Cancer Res; 2023 Sep; 83(17):2952-2969. PubMed ID: 37335139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell profiling of the microenvironment in human bone metastatic renal cell carcinoma.
    Ma F; Wang S; Xu L; Huang W; Shi G; Sun Z; Cai W; Wu Z; Huang Y; Meng J; Sun Y; Fang M; Cheng M; Ji Y; Hu T; Zhang Y; Gu B; Zhang J; Song S; Sun Y; Yan W
    Commun Biol; 2024 Jan; 7(1):91. PubMed ID: 38216635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response.
    Hajiran A; Chakiryan N; Aydin AM; Zemp L; Nguyen J; Laborde JM; Chahoud J; Spiess PE; Zaman S; Falasiri S; Fournier M; Teer JK; Dhillon J; McCarthy S; Moran-Segura C; Katende EN; Sexton WJ; Koomen JM; Mulé J; Kim Y; Manley B
    Clin Exp Immunol; 2021 Apr; 204(1):96-106. PubMed ID: 33346915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs.
    Beuselinck B; Jean-Baptiste J; Couchy G; Job S; De Reynies A; Wolter P; Théodore C; Gravis G; Rousseau B; Albiges L; Joniau S; Verkarre V; Lerut E; Patard JJ; Schöffski P; Méjean A; Elaidi R; Oudard S; Zucman-Rossi J
    Br J Cancer; 2015 Nov; 113(9):1313-22. PubMed ID: 26528707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
    Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
    Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8
    Monteiro AC; Bonomo A
    Bone; 2021 Sep; 150():116014. PubMed ID: 34022456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
    Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
    PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
    Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
    Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma.
    Zhang D; Ni Y; Wang Y; Feng J; Zhuang N; Li J; Liu L; Shen W; Zheng J; Zheng W; Qian C; Shan J; Zhou Z
    J Transl Med; 2023 Jul; 21(1):489. PubMed ID: 37474942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
    Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
    PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
    Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
    Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature.
    Mei S; Alchahin AM; Embaie BT; Gavriliuc IM; Verhoeven BM; Zhao T; Li X; Jeffries NE; Pepich A; Sarkar H; Olsen TK; Wickström M; Stenman J; Reina-Bedoya O; Kharchenko PV; Saylor PJ; Johnsen JI; Sykes DB; Kogner P; Baryawno N
    JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38358826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.